Go Pro
OTCMKTS:AFFY

Affymax (AFFY) Stock Price, News & Analysis

Affymax logo
$0.0016 0.00 (0.00%)
As of 10/1/2026

About Affymax Stock (OTCMKTS:AFFY)

Advanced

Key Stats

Today's Range
$0.0016
▼
$0.0016
50-Day Range
N/A
52-Week Range
$0.00
▼
$0.04
Volume
N/A
Average Volume
1,630 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Affymax, Inc. was a biopharmaceutical company focused on discovering and developing peptide-based medicines for serious medical conditions. Its research platform was designed to identify novel therapeutic compounds with potential applications across a range of disease areas.

The company’s principal product was peginesatide, marketed in the United States as Omontys. Peginesatide was developed to treat anemia associated with chronic kidney disease and received U.S. regulatory approval in 2012. The product was voluntarily withdrawn from the market in 2013 after reports of serious hypersensitivity reactions, including deaths.

Following the withdrawal of Omontys, Affymax discontinued its commercial operations and pursued restructuring and bankruptcy proceedings. The company is primarily associated with its historical drug-development activities rather than an active portfolio of marketed products or services.

AI Generated. May Contain Errors.

Receive AFFY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Affymax and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AFFY Stock News Headlines

Affymax, Inc. (AFFY)
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.tc pixel
4 Biotech Stocks Under $5 to Watch
See More Headlines

AFFY Stock Analysis - Frequently Asked Questions

Affymax's stock was trading at $0.0008 at the start of the year. Since then, AFFY shares have increased by 100.0% and is now trading at $0.0016.

Shares of AFFY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Affymax investors own include Golden Peak Minerals Inc.. (GRM), Bank of America (BAC), Boeing (BA), American Express (AXP) and Aurinia Pharmaceuticals (AUPH).

Company Calendar

Today
10/02/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
OTCMKTS:AFFY
CIK
1158223
Employees
2
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
7.00
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (OTCMKTS:AFFY) was last updated on 10/2/2026 by MarketBeat.com Staff.
From Our Partners